The findings closest to your search, judged one by one by TypeSafe's Jev model.
It is very uncertain whether oral drug treatment changes primary outcome 2: Clinical recurrence at 6 months compared with topical drug treatment (very low certainty).
It is very uncertain whether oral drug treatment changes primary outcome 2: Clinical recurrence at 12 months compared with topical drug treatment (very low certainty).
Drug treatment may leads to lower primary outcome 2: Clinical recurrence at 6 months compared with placebo or no treatment (low certainty).
Drug treatment may leads to lower primary outcome 2: Clinical recurrence at 12 months compared with placebo or no treatment (low certainty).
Short‐duration antiepileptic drug treatment showed no clear difference in seizure control(seizure recurrence) compared with long‐duration antiepileptic drug treatment (low certainty).
It is very uncertain whether six‐ to 12‐month antiepileptic drug treatment changes seizure control (seizure recurrence) compared with 24‐month antiepileptic drug treatment (very low certainty).
Maintenance treatment with antipsychotic drugs leads to lower leaving the study early: due to any reason (acceptability of… compared with placebo/no treatment (high certainty).
The review found no eligible studies for this question.
It is very uncertain whether are disease‐modifying drugs for a first attack suggestive of… changes withdrawls or drug discontinuation due to adverse events during 24… compared with placebo? (very low certainty).
Maintenance treatment with antipsychotic drugs leads to lower relapse: 7 to 12 months compared with placebo/no treatment (high certainty).
Maintenance treatment with antipsychotic drugs leads to lower service use: number of participants hospitalised compared with placebo/no treatment (high certainty).
Maintenance treatment with antipsychotic drugs showed no clear difference in death: due to suicide compared with placebo/no treatment (low certainty).
Maintenance treatment with antipsychotic drugs showed no clear difference in number of participants in employment compared with placebo/no treatment (low certainty).